By Michele Maatouk
Date: Thursday 07 Nov 2024
(Sharecast News) - Investment fund Oaktree Capital Management has written to Indivior urging the opioid addiction treatment maker to refresh its board with directors "committed to taking all steps necessary to improve shareholder value".
By Josh White
Date: Thursday 24 Oct 2024
(Sharecast News) - London's stock markets ended Thursday with mixed results, with the top-flight index held aloft by strong earnings reports from major companies like Unilever and Barclays, as investors digested a slew of US data.
By Josh White
Date: Thursday 24 Oct 2024
(Sharecast News) - Addiction treatment specialist Indivior reported a strong third-quarter performance on Thursday, with total net revenue increasing 13% to $307m compared to the same period last year, after it recently updated its full-year guidance.
Currency | UK Pounds |
Share Price | 789.50p |
Change Today | -2.50p |
% Change | -0.32 % |
52 Week High | 1,764.00 |
52 Week Low | 576.50 |
Volume | 759,828 |
Shares Issued | 127.14m |
Market Cap | £1,003.75m |
Beta | 1.50 |
RiskGrade | 314 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
No dividends found |
Time | Volume / Share Price |
16:38 | 495 @ 789.50p |
16:35 | 20,526 @ 789.50p |
16:35 | 249,285 @ 789.50p |
16:35 | 144 @ 789.50p |
16:35 | 1,193 @ 789.50p |
CEO | Mark Crossley |
Chair | Graham Hetherington |
You are here: research